Methylbenactyzium Bromide
Methylbenactyzium Bromide is a muscarinic acetylcholine receptor (mAChR) inhibitor.
Product Specifications
CAS Number
3166-62-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Methylbenactyzium_Bromide.html
Concentration
10mM
Purity
99.53
Solubility
DMSO : 6 mg/mL (ultrasonic; warming) |H2O : 100 mg/mL (ultrasonic)
Smiles
O=C(OCC[N+](CC)(CC)C)C(C1=CC=CC=C1)(O)C2=CC=CC=C2.[Br-]
Molecular Formula
C21H28BrNO3
Molecular Weight
422.36
Precautions
H302, H315, H319, H335
References & Citations
[1]Bhattacharjee AK, et al. Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods. Bioorg Med Chem. 2013 May 1;21 (9) :2651-62.|[2]Nishikawa M, et al. Analysis of methylbenactyzium bromide in human urine by thin-layer chromatography and pyrolysis gas chromatography. Forensic Sci Int. 1991 Mar;49 (2) :197-203.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 